OCC 20.9% 66.5¢ orthocell limited

Reminder - J&J ATI Rotator Cuff clinical trial update coming soon, page-157

  1. 1,666 Posts.
    lightbulb Created with Sketch. 178
    HD, I wonder how much closer we are to
    commercialisation for ATI. Surely, still nowhere
    near phase 3 trial for FDA. I don’t know, maybe
    we don’t need one? It’s bloody frustrating.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.